(4-isothiocyanatophenyl)(4-methoxyphenyl)amine, 95.0%, 1g

N,N-Diisopropylethylamine (DIPEA), 100mL, >=99.5%, for peptide synthesis, glass packaging

6-Chloro-m-anisidine hydrochloride, 96.0%, 25g

(5Z)-5-[[5-(4-Fluoro-2-hydroxyphenyl)-2-furanyl]methylene]-2,4-thiazolidinedione, 98%, 5mg

methyl 2-amino-6-propyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylate, 95.0%, 250mg

n-Benzyl-4-methoxybenzene-1-sulfonamide, 95%, 100mg

1,3,2-Dioxathiane 2-oxide, 98.0%, 10g

(3-Hydroxy-4-methoxyphenyl)boronic acid, 95.0%, 1g

2-METHOXY-5-(2-PYRROLIDINYL)PYRIDINE, 95.0%, 100mg

(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine hemi((2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinate), 97%, 100mg

Lomefloxacin Hydrochloride>98.0%(HPLC)(T)5g

2-Chlorobenzo[d]isothiazol-3(2H)-one 1,1-dioxide, 95.0%, 1g

2-amino-3-phenylpropanenitrile hydrochloride, 95.0%, 250mg